Policy / Pricing Medicare obesity drug pilot extended after insurer pushback PharmaphorumMedicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.Policy / PricingMetabolic & GLP-1Read full story pharminent April 22, 2026 (Last updated: April 22, 2026) Pharmaphorum Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part. Policy / PricingMetabolic & GLP-1Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Health Canada approves Biocon’s two denosumab biosimilarsNext: BioAegis and Prenosis partner for inflammatory disease therapies Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
